The global burden of lung cancer: current status and future trends
A Leiter, RR Veluswamy, JP Wisnivesky - Nature reviews Clinical …, 2023 - nature.com
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …
incidence and mortality rates differ substantially across the world, reflecting varying patterns …
Epidemiology and prevention of prostate cancer
Abstract Context Worldwide, prostate cancer (PCa) represents the second most common
solid tumor in men. Objective To assess the geographical distribution of PCa …
solid tumor in men. Objective To assess the geographical distribution of PCa …
[HTML][HTML] The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
Introduction Europe is an important focus for compiling accurate and up-to-date world
cancer statistics owing to its large share of the world's total cancer burden. This article …
cancer statistics owing to its large share of the world's total cancer burden. This article …
[HTML][HTML] Updates and new options in advanced epithelial ovarian cancer treatment
Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic
prostate cancer and died of the disease; after the introduction of the serum PSA test …
prostate cancer and died of the disease; after the introduction of the serum PSA test …
[HTML][HTML] European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Background We predicted cancer mortality statistics for 2021 for the European Union (EU)
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
Intensive care unit mortality prediction: An improved patient-specific stacking ensemble model
The intensive care unit (ICU) admits the most seriously ill patients requiring extensive
monitoring. Early ICU mortality prediction is crucial for identifying patients who are at great …
monitoring. Early ICU mortality prediction is crucial for identifying patients who are at great …
Point-of-Care prostate specific antigen testing: examining translational progress toward clinical implementation
Prostate cancer (PCa) is the second most common male cancer and is attributable to over
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …
Benefits and harms of lung cancer screening by chest computed tomography: a systematic review and meta-analysis
F Passiglia, M Cinquini, L Bertolaccini… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This meta-analysis aims to combine and analyze randomized clinical trials
comparing computed tomography lung screening (CTLS) versus either no screening (NS) or …
comparing computed tomography lung screening (CTLS) versus either no screening (NS) or …
[HTML][HTML] Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
KJ Frank, A Mulero-Sanchez, A Berninger… - Cell Reports …, 2022 - cell.com
Over 90% of pancreatic cancers present mutations in KRAS, one of the most common
oncogenic drivers overall. Currently, most KRAS mutant isoforms cannot be targeted directly …
oncogenic drivers overall. Currently, most KRAS mutant isoforms cannot be targeted directly …